Skip to main content

01.12.2010 | Original Article

Review of primary unknown cancer: cases referred to the National Cancer Center Hospital East

Erschienen in: International Journal of Clinical Oncology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Primary unknown cancer (PUC) is not rare neoplasm. The clinical features and survival time of these patients are heterogeneous. We analyzed cases that were referred to the National Cancer Center Hospital East with preliminary diagnosed PUC to evaluate the natural history and clinical features.

Methods

We retrospectively reviewed medical records of PUC patients who were referred to our institution between August 2005 and December 2008.

Results

One hundred and twenty-six patients with preliminary diagnoses of PUC were referred to the National Cancer Center Hospital East from community hospitals. The median age was 63 years (range 31–89 years). Almost all patients (85.7%) had good performance status (0–1). The mean interval between the first visit to a community hospital and referral to our hospital was 3.66 months (range 0–60 months). In 41 patients (32.5%), primary malignancies were identified by immunohistochemical studies and radiographical workup after referral to our hospital. Twenty-eight patients (22.2%) were defined as belonging to favorable subsets. About 50% of patients with unfavorable subsets received chemotherapy. None of the patients were autopsied.

Conclusion

In about half of the patients with preliminary diagnosed PUC, the primary origin could be identified, or it was possible to distinguish subsets with favorable prognosis.
Literatur
2.
Zurück zum Zitat Levi F, Te VC, Erler G et al (2002) Epidemiology of unknown primary tumours. Eur J Cancer 38:1810–1812PubMedCrossRef Levi F, Te VC, Erler G et al (2002) Epidemiology of unknown primary tumours. Eur J Cancer 38:1810–1812PubMedCrossRef
3.
Zurück zum Zitat Nystrom JS, Weiner JM, Heffelfinger-Juttner J et al (1977) Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 4:53–58PubMed Nystrom JS, Weiner JM, Heffelfinger-Juttner J et al (1977) Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 4:53–58PubMed
4.
Zurück zum Zitat Nystrom JS, Weiner JM, Wolf RM et al (1979) Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. JAMA 241:381–383PubMedCrossRef Nystrom JS, Weiner JM, Wolf RM et al (1979) Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. JAMA 241:381–383PubMedCrossRef
5.
Zurück zum Zitat Pavlidis N, Briasoulis E, Hainsworth J et al (2003) Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39:1990–2005PubMedCrossRef Pavlidis N, Briasoulis E, Hainsworth J et al (2003) Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39:1990–2005PubMedCrossRef
6.
Zurück zum Zitat Culine S, Kramar A, Saghatchian M et al (2002) Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 20:4679–4683PubMedCrossRef Culine S, Kramar A, Saghatchian M et al (2002) Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 20:4679–4683PubMedCrossRef
7.
Zurück zum Zitat van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW et al (2002) Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992. Eur J Cancer 38:409–413PubMedCrossRef van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW et al (2002) Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992. Eur J Cancer 38:409–413PubMedCrossRef
8.
Zurück zum Zitat Yakushiji S, Ando M, Yonemori K et al (2006) Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan. Int J Clin Oncol 11:421–425PubMedCrossRef Yakushiji S, Ando M, Yonemori K et al (2006) Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan. Int J Clin Oncol 11:421–425PubMedCrossRef
9.
Zurück zum Zitat Abbruzzese JL, Abbruzzese MC, Hess KR et al (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12:1272–1280PubMed Abbruzzese JL, Abbruzzese MC, Hess KR et al (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12:1272–1280PubMed
10.
Zurück zum Zitat Altman E, Cadman E (1986) An analysis of 1539 patients with cancer of unknown primary site. Cancer 57:120–124PubMedCrossRef Altman E, Cadman E (1986) An analysis of 1539 patients with cancer of unknown primary site. Cancer 57:120–124PubMedCrossRef
11.
Zurück zum Zitat Milliken ST, Tattersall MH, Woods RL et al (1987) Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens. Eur J Cancer Clin Oncol 23:1645–1648PubMedCrossRef Milliken ST, Tattersall MH, Woods RL et al (1987) Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens. Eur J Cancer Clin Oncol 23:1645–1648PubMedCrossRef
12.
Zurück zum Zitat Falkson CI, Cohen GL (1998) Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin. Oncology 55:116–121PubMedCrossRef Falkson CI, Cohen GL (1998) Mitomycin C, epirubicin and cisplatin versus mitomycin C alone as therapy for carcinoma of unknown primary origin. Oncology 55:116–121PubMedCrossRef
13.
Zurück zum Zitat Eagan RT, Therneau TM, Rubin J et al (1987) Lack of value for cisplatin added to mitomycin–doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial. Am J Clin Oncol 10:82–85PubMedCrossRef Eagan RT, Therneau TM, Rubin J et al (1987) Lack of value for cisplatin added to mitomycin–doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial. Am J Clin Oncol 10:82–85PubMedCrossRef
14.
Zurück zum Zitat NCCN Practice Guidelines for Occult Primary Tumors (1998) National Comprehensive Cancer Network. Oncology (Williston Park) 12:226–309 NCCN Practice Guidelines for Occult Primary Tumors (1998) National Comprehensive Cancer Network. Oncology (Williston Park) 12:226–309
15.
Zurück zum Zitat Su AI, Welsh JB, Sapinoso LM et al (2001) Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61:7388–7393PubMed Su AI, Welsh JB, Sapinoso LM et al (2001) Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61:7388–7393PubMed
16.
Zurück zum Zitat Bloom G, Yang IV, Boulware D et al (2004) Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 164:9–16PubMed Bloom G, Yang IV, Boulware D et al (2004) Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 164:9–16PubMed
17.
Zurück zum Zitat Varadhachary GR, Talantov D, Raber MN et al (2008) Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 26:4442–4448PubMedCrossRef Varadhachary GR, Talantov D, Raber MN et al (2008) Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 26:4442–4448PubMedCrossRef
18.
Zurück zum Zitat Mayordomo JI, Guerra JM, Guijarro C et al (1993) Neoplasms of unknown primary site: a clinicopathological study of autopsied patients. Tumori 79:321–324PubMed Mayordomo JI, Guerra JM, Guijarro C et al (1993) Neoplasms of unknown primary site: a clinicopathological study of autopsied patients. Tumori 79:321–324PubMed
19.
Zurück zum Zitat Bugat R, Bataillard A, Lesimple T et al (2003) Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). Br J Cancer 89(Suppl 1):S59–S66PubMedCrossRef Bugat R, Bataillard A, Lesimple T et al (2003) Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). Br J Cancer 89(Suppl 1):S59–S66PubMedCrossRef
Metadaten
Titel
Review of primary unknown cancer: cases referred to the National Cancer Center Hospital East
Publikationsdatum
01.12.2010
Erschienen in
International Journal of Clinical Oncology / Ausgabe 6/2010
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0112-3

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.